Sign in
4

Changes in Ownership

TREACE MEDICAL CONCEPTS, INC. Filed Acc 0001209191-23-030857

Chief Innovation Officer sold 25,000 shares at $25.44 ($635,978)

  • Chief Innovation Officer acquired 25,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Scanlan Sean F. · Chief Innovation Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2023-05-16 Exercise or conversion : show line 1 in the form +25,000 $0.10 $2,500 57,395 D
2023-05-16 Sale : show line 2 in the form −25,000 $25.44 $635,978 32,395 D
Open-market sales · 25,000 sh · avg $25.44 · $635,978

Table II: Derivative

1 line
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2023-05-16 Exercise or conversion : show line 3 in the form Stock Option (Right to Buy) −25,000 $0.10 2024-12-15 25,000 33,750 D
Loading xslF345X04/doc4.xml…